Essential Reviews in Geriatric Psychiatry

Foreword
Preface
Acknowledgment
Contents
Contributors
Part I: Adverse Effects of Medications
	Chapter 1: Do Atypical Antipsychotics Cause Stroke?
		Reference
	Chapter 2: Risk of Death with Atypical Antipsychotic Drug Treatment for Dementia: Meta-analysis of Randomized Placebo-Controlled Trials
		References
	Chapter 3: Meta-analysis of the Impact of Nine Medication Classes on Falls in Elderly Persons
		References
	Chapter 4: The Efficacy and Safety of Atypical Antipsychotics for the Treatment of Dementia: A Meta-analysis of Randomized Placebo-Controlled Trials
		References
	Chapter 5: Do Antipsychotics Lead to Cognitive Impairment in Dementia? A Meta-analysis of Randomized Placebo-Controlled Trials
		References
	Chapter 6: A Systematic Review and Meta-analysis of the Risk of Dementia Associated with Benzodiazepine Use, After Controlling for Protopathic Bias
		References
Part II: Anxiety Disorders
	Chapter 7: Treatment of Panic Disorder in Older Adults: A Pilot Study Comparison of Alprazolam, Imipramine, and Placebo
		References
	Chapter 8: Efficacy and Tolerability of Citalopram in the Treatment of Late-Life Anxiety Disorders: Results from an 8-Week Randomized, Placebo-Controlled Trial
		References
	Chapter 9: Efficacy and Tolerability of Duloxetine in Elderly Patients with Generalized Anxiety Disorder: A Pooled Analysis of Four Randomized, Double-Blind, Placebo-Controlled Studies
		References
	Chapter 10: Escitalopram for Older Adults with Generalized Anxiety Disorder: A Randomized Controlled Trial
		References
	Chapter 11: Meta-analysis Comparing Different Behavioral Treatments for Late-Life Anxiety
		Reference
	Chapter 12: Cognitive Behavior Therapy for Generalized Anxiety Disorder Among Older Adults in Primary Care: A Randomized Clinical Trial
		References
	Chapter 13: Stepped-Care Prevention of Anxiety and Depression in Late Life: A Randomized Controlled Trial
		References
	Chapter 14: A Randomized Controlled Study of Paroxetine and Cognitive Behavioral Therapy for Late-Life Panic Disorder
		References
	Chapter 15: Antidepressant Medication Augmented with Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults
		Reference
	Chapter 16: A Meta-Analysis of Cognitive Functioning in Older Adults with PTSD
		References
	Chapter 17: Anxiety as a Predictor for Cognitive Decline and Dementia: A Systematic Review and Meta-Analysis
		References
Part III: Bipolar Disorder
	Chapter 18: A Pilot Study of Standardized Treatment in Geriatric Bipolar Disorder
		References
	Chapter 19: Differences in Clinical Features and Mental Health Service Use in Bipolar Disorder Across the Life Span
		References
	Chapter 20: Effect of Antidepressant Use on Admissions to Hospital Among Elderly Bipolar Patients
		References
	Chapter 21: GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients with Bipolar Disorder
		References
	Chapter 22: History of Bipolar Disorder and the Risk of Dementia: A Systematic Review and Meta-Analysis
		References
Part IV: Delirium
	Chapter 23: A Multicomponent Intervention to Prevent Delirium in Hospitalized Older Patients
		References
	Chapter 24: Delirium in Elderly Patients and the Risk of Post-Discharge Mortality, Institutionalization, and Dementia: A Meta-Analysis
		Reference
	Chapter 25: Effectiveness of Multicomponent Nonpharmacological Delirium Interventions: A Meta-Analysis
		Reference
	Chapter 26: Antipsychotic Medication for Prevention and Treatment of Delirium in Hospitalized Adults: A Systematic Review and Meta-Analysis
		Reference
	Chapter 27: Interventions for Preventing Delirium in Older People in Institutional Long-Term Care
		References
Part V: Depressive Disorders
	Chapter 28: Nortriptyline and Interpersonal Psychotherapy as Maintenance Therapies for Recurrent Major Depression: A Randomized Controlled Trial in Patients Older than 59 Years
		References
	Chapter 29: Continuation Treatment of Delusional Depression in Older Adults
		References
	Chapter 30: Reducing Suicidal Ideation and Depressive Symptoms in Depressed Older Primary Care Patients: A Randomized Controlled Trial
		References
	Chapter 31: Remission in Depressed Geriatric Primary Care Patients: A Report from the PROSPECT Study
		References
	Chapter 32: Executive Dysfunction and the Course of Geriatric Depression
		Reference
	Chapter 33: Maintenance Treatment of Major Depression in Old Age
		References
	Chapter 34: Placebo-Controlled Study of Relapse Prevention with Risperidone Augmentation in Older Patients with Resistant Depression
		Reference
	Chapter 35: Efficacy of Second-Generation Antidepressants in Late-Life Depression: A Meta-analysis of the Evidence
		References
	Chapter 36: A Double-Blind Randomized Controlled Trial of Olanzapine Plus Sertraline Versus Olanzapine Plus Placebo for Psychotic Depression: The Study of Pharmacotherapy of Psychotic Depression (STOP-PD)
		References
	Chapter 37: Speed of Remission in Elderly Patients with Depression: Electroconvulsive Therapy Versus Medication
		References
	Chapter 38: A Systematic Review and Meta-analysis of Psychotherapy for Late-Life Depression
		References
	Chapter 39: A Novel Strategy for Continuation ECT in Geriatric Depression: Phase 2 of the PRIDE Study
		References
	Chapter 40: Right Unilateral Ultrabrief Pulse ECT in Geriatric Depression: Phase 1 of the PRIDE Study
		Reference
	Chapter 41: Improvement in Depression Is Associated with Improvement in Cognition in Late-Life Psychotic Depression
		References
Part VI: Electroconvulsive Therapy
	Chapter 42: Continuation/Maintenance Treatment with Nortriptyline Versus Combined Nortriptyline and ECT in Late-Life Psychotic Depression: A Two-Year Randomized Study
		References
	Chapter 43: Safety and Utility of Acute Electroconvulsive Therapy for Agitation and Aggression in Dementia
		Reference
	Chapter 44: Electroconvulsive Therapy and Risk of Dementia in Patients with Affective Disorders: A Cohort Study
		References
	Chapter 45: Electroconvulsive Therapy and Risk of Dementia: A Nationwide Cohort Study in Taiwan
		References
Part VII: Grief
	Chapter 46: Treatment of Complicated Grief in Elderly Persons: A Randomized Clinical Trial
		References
Part VIII: Pain Disorders
	Chapter 47: Association Between Psychological Interventions and Chronic Pain Outcomes in Older Adults: A Systematic Review and Meta-Analysis
		References
Part IX: Psychotic Disorders
	Chapter 48: A Randomized Controlled Trial of Cognitive Behavioral Social Skills Training for Middle-Aged and Older Outpatients with Chronic Schizophrenia
		References
	Chapter 49: Safety and Tolerability of Oral Paliperidone Extended-Release Tablets in Elderly Patients with Schizophrenia: A Double-Blind, Placebo-Controlled Study with Six-Month Open-Label Extension
		References
	Chapter 50: Antipsychotic Treatment for Elderly People with Late-Onset Schizophrenia
		Reference
	Chapter 51: Schizophrenia and Risk of Dementia: A Meta-Analysis Study
		Reference
	Chapter 52: Antipsychotic Treatment of Very Late-Onset Schizophrenia-Like Psychosis (ATLAS): A Randomized, Controlled, Double-Blind Trial
		References
Part X: Neurocognitive Disorders
	Chapter 53: Efficacy and Safety of Cholinesterase Inhibitors in Alzheimer’s Disease: A Meta-analysis
		References
	Chapter 54: Depression and Risk for Alzheimer’s Disease: Systematic Review, Meta-analysis, and Metaregression Analysis
		References
	Chapter 55: Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer’s Disease
		References
	Chapter 56: Predictors of Progression from Mild Cognitive Impairment to Alzheimer’s Disease
		References
	Chapter 57: Efficacy and Safety of Cognitive Enhancers for Patients with Mild Cognitive Impairment: A Systematic Review and Meta-analysis
		References
	Chapter 58: Personality and Risk of Alzheimer’s Disease: New Data and Meta-analysis
		References
	Chapter 59: Modifiable Predictors of Dementia in Mild Cognitive Impairment: A Systematic Review and Meta-analysis
		References
	Chapter 60: Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-analysis
		Reference
	Chapter 61: Meta-analysis of Modifiable Risk Factors of Alzheimer’s Disease
		References
	Chapter 62: Memantine for Alzheimer’s Disease: An Updated Systematic Review and Meta-analysis
		Reference
	Chapter 63: Update on the Risk of Motor Vehicle Collision or Driving Impairment with Dementia: A Collaborative International Systematic Review and Meta-analysis
		References
	Chapter 64: Pharmacological Interventions for Apathy in Alzheimer’s Disease
		References
Part XI: Sleep Disorders
	Chapter 65: Behavioral and Pharmacological Therapies for Late-Life Insomnia: A Randomized Controlled Trial
		References
	Chapter 66: Cognitive Behavioral Therapy Versus Zopiclone for the Treatment of Chronic Primary Insomnia in Older Adults: A Randomized Controlled Trial
		References
	Chapter 67: Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical Trials
		References
	Chapter 68: Cognitive Behavioral Therapy for Older Adults with Insomnia and Depression: A Randomized Controlled Trial in Community Mental Health Services
		References
Part XII: Suicides
	Chapter 69: Medical Illness and the Risk of Suicide in the Elderly
		Reference
	Chapter 70: The Risk of Suicide with Selective Serotonin Reuptake Inhibitors in the Elderly
		Reference
Part XIII: Substance Use Disorders
	Chapter 71: Naltrexone as an Adjunctive Treatment for Older Patients with Alcohol Dependence
		References
	Chapter 72: Older Adult Patients with Both Psychiatric and Substance Abuse Disorders: Prevalence and Health Service Use
		Reference
	Chapter 73: Five-Year Alcohol and Drug Treatment Outcomes of Older Adults Versus Middle-Aged and Younger Adults in a Managed Care Program
		Reference
	Chapter 74: Treatment of Late-Life Depression Complicated by Alcohol Dependence
		References
	Chapter 75: Screening and Brief Intervention for Substance Misuse Among Older Adults: The Florida BRITE Project
		References
Index